Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$309K Buy
2,408
+23
+1% +$2.69K 0.09% 68
2026
Q1
$287K Buy
2,385
+38
+2% +$4.39K 0.09% 66
2025
Q4
$247K Buy
+2,347
New +$220K 0.08% 65
2025
Q2
Sell
-2,512
Closed -$225K 71
2025
Q1
$225K Sell
2,512
-58
-2% -$5.42K 0.09% 59
2024
Q4
$256K Sell
2,570
-320
-11% -$33K 0.1% 55
2024
Q3
$328K Sell
2,890
-230
-7% -$27.3K 0.13% 50
2024
Q2
$386K Sell
3,120
-380
-11% -$48.9K 0.17% 41
2024
Q1
$462K Buy
3,500
+26
+0.7% +$3.21K 0.2% 35
2023
Q4
$379K Buy
3,474
+52
+2% +$5.4K 0.18% 38
2023
Q3
$352K Sell
3,422
-29
-0.8% -$3.13K 0.19% 40
2023
Q2
$398K Buy
3,451
+11
+0.3% +$1.25K 0.2% 35
2023
Q1
$366K Buy
3,440
+66
+2% +$7.13K 0.2% 36
2022
Q4
$374K Sell
3,374
-33
-1% -$3.37K 0.22% 32
2022
Q3
$293K Sell
3,407
-116
-3% -$10.4K 0.2% 34
2022
Q2
$321K Buy
3,523
+275
+8% +$24.4K 0.21% 36
2022
Q1
$266K Buy
+3,248
New +$256K 0.15% 41
2021
Q2
Sell
-2,743
Closed -$201K 59
2021
Q1
$201K Sell
2,743
-144
-5% -$10.6K 0.12% 54
2020
Q4
$228K Sell
2,887
-110
-4% -$8.41K 0.13% 75
2020
Q3
$237K Buy
2,997
+13
+0.4% +$1.02K 0.16% 66
2020
Q2
$220K Buy
2,984
+12
+0.4% +$903 0.17% 48
2020
Q1
$218K Buy
2,972
+11
+0.4% +$865 0.19% 63
2019
Q4
$256K Buy
2,961
+11
+0.4% +$903 0.17% 65
2019
Q3
$236K Buy
2,950
+10
+0.3% +$801 0.17% 67
2019
Q2
$235K Buy
2,940
+12
+0.4% +$919 0.17% 63
2019
Q1
$232K Buy
2,928
+116
+4% +$8.68K 0.19% 43
2018
Q4
$205K Buy
+2,812
New +$199K 0.18% 75
2018
Q1
Sell
-2,101
Closed -$110K 357
2017
Q4
$110K Buy
+2,101
New +$116K 0.1% 70

Other funds holding MRK

Santori & Peters Inc's MRK Position: Q2 2026 in Review

Santori & Peters Inc increased its Merck (MRK) stake by 0.96% in Q2 2026, buying an estimated $2.69K and bringing the position to 2,408 shares worth $309K. The position accounts for 0.09% of the portfolio, ranked #68.

Santori & Peters Inc first reported a position in MRK in Q4 2017 and has held it in 27 quarters since. The position peaked at $462K in Q1 2024. 1,860 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Santori & Peters Inc held 2,408 shares of Merck worth $309K as of Q2 2026.
  • Santori & Peters Inc bought 23 Merck shares in Q2 2026, an estimated $2.69K.
  • Merck made up 0.09% of Santori & Peters Inc's portfolio in Q2 2026, its #68 holding.
  • Santori & Peters Inc first reported a position in Merck in Q4 2017 and has held it in 27 quarters since.
  • Santori & Peters Inc's Merck position peaked at $462K in Q1 2024.
  • 1,860 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Santori & Peters Inc's 13F filing for Q2 2026, filed 24 Jul 2026.